Anthony J. Mirando

Anthony J. Mirando

Auto-generated profile, based on publicly available information

Anthony J. Mirando

Departments of Orthopaedic Surgery, Duke Orthopaedic Cellular, Developmental, and Genome Laboratories, Duke University School of Medicine, Durham, NC 27710, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Science Signaling
Verified
Journal Article
Closed access
YLYihan Liao
Yihan Liao
YRYinshi Ren
Yinshi Ren
XLXin Luo
Xin Luo
AMAnthony J. Mirando
Anthony J. Mirando
JLJason T. Long
Jason T. Long
MHMatthew J. Hilton
Matthew J. Hilton
Osteoarthritis (OA) and posttraumatic OA (PTOA) are caused by an imbalance in catabolic and anabolic processes in articular cartilage and proinflammatory changes throughout the joint, leading to joint degeneration and pain. We examined whether interleukin-6 (IL-6) signaling contributed to cartilage degradation and pain in PTOA. Genetic ablation of Il6 in male mice decreased PTOA-associated cartilage catabolism, innervation of the knee joint, and nociceptive signaling without improving PTOA-associated subchondral bone sclerosis or chondrocyte apoptosis. These effects were not observed in female Il6 −/− mice. Compared with wild-type mice, the activation of the IL-6 downstream mediators STAT3 and ERK was reduced in the knees and dorsal root ganglia (DRG) of male Il6 −/− mice after knee injury. Janus kinases (JAKs) were critical for STAT and ERK signaling in cartilage catabolism and DRG pain signaling in tissue explants. Whereas STAT3 signaling was important for cartilage catabolism, ERK signaling mediated neurite outgrowth and the activation of nociceptive neurons. These data demonstrate that IL-6 mediates both cartilage degradation and pain associated with PTOA in a sex-specific manner and identify tissue-specific contributions of downstream effectors of IL-6 signaling, which are potential therapeutic targets for disease-modifying OA drugs.

10 May 2022 in Cell Reports
Verified
Journal Article
Open access
ALAbigail P. Leinroth
Abigail P. Leinroth
AMAnthony J. Mirando
Anthony J. Mirando
DRDouglas Rouse
Douglas Rouse
YKYoshihiko Kobayahsi
Yoshihiko Kobayahsi
PTPurushothama Rao Tata
Purushothama Rao Tata
MHMatthew J. Hilton
Matthew J. Hilton
Mesenchymal progenitors of the lateral plate mesoderm give rise to various cell fates within limbs, including a heterogeneous group of muscle-resident mesenchymal cells. Often described as fibro-adipogenic progenitors, these cells are key players in muscle development, disease, and regeneration. To further define this cell population(s), we perform lineage/reporter analysis, flow cytometry, single-cell RNA sequencing, immunofluorescent staining, and differentiation assays on normal and injured murine muscles. Here we identify six distinct Pdgfra+ non-myogenic muscle-resident mesenchymal cell populations that fit within a bipartite differentiation trajectory from a common progenitor. One branch of the trajectory gives rise to two populations of immune-responsive mesenchymal cells with strong adipogenic potential and the capability to respond to acute and chronic muscle injury, whereas the alternative branch contains two cell populations with limited adipogenic capacity and inherent mineralizing capabilities; one of the populations displays a unique neuromuscular junction association and an ability to respond to nerve injury.

20 December 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
DSDeepika Sharma
Deepika Sharma
AMAnthony J. Mirando
Anthony J. Mirando
ALAbigail Leinroth
Abigail Leinroth
JLJason T. Long
Jason T. Long
CKCourtney Karner
Courtney Karner
MHMatthew J. Hilton
Matthew J. Hilton
Sonic Hedgehog/GLI3 signaling is critical in regulating digit number, such that Gli3-deficiency results in polydactyly and Shh-deficiency leads to digit number reductions. SHH/GLI3 signaling regulates cell cycle factors controlling mesenchymal cell proliferation, while simultaneously regulatingGrem1to coordinate BMP-induced chondrogenesis. SHH/GLI3 signaling also coordinates the expression of additional genes, however their importance in digit formation remain unknown. Utilizing genetic and molecular approaches, we identified HES1 as a downstream modifier of the SHH/GLI signaling axis capable of inducing preaxial polydactyly (PPD), required for Gli3-deficient PPD, and capable of overcoming digit number constraints of Shh-deficiency. Our data indicate that HES1, a direct SHH/GLI signaling target, induces mesenchymal cell proliferation via suppression ofCdkn1b, while inhibiting chondrogenic genes and the anterior autopod boundary regulator,Pax9. These findings establish HES1 as a critical downstream effector of SHH/GLI3 signaling in the development of PPD.